Inventurus Knowledge Solutions Lists at ₹1,900, 43% Above IPO Price
Sandip Raj Gupta
19/Dec/2024

What's Covered Under the Article
- Inventurus Knowledge Solutions shares debut at ₹1,900 on NSE and ₹1,856 on BSE.
- IPO was oversubscribed 52.68 times, reflecting strong investor demand.
- Company specializes in healthcare IT solutions with 75% revenue growth in FY24.
Inventurus Knowledge Solutions (IKS Health) made a remarkable stock market debut on December 18, 2024, listing at ₹1,900 on NSE, representing a 43% premium over its upper IPO price band of ₹1,329. On the BSE, the stock opened at ₹1,856, a 39.65% gain.
The company’s listing performance reflects strong investor confidence, backed by robust subscription figures during the IPO period from December 12 to December 16, 2024.
IPO Subscription and Details
The Inventurus Knowledge Solutions IPO, valued at ₹2,497.92 crores, garnered significant demand from all investor categories. The issue was oversubscribed 52.68 times, with bids for 54.60 crore shares against 1.03 crore shares on offer.
Here’s the category-wise subscription breakdown:
- Retail Investors: Subscribed 14.55 times.
- Non-Institutional Investors (NII): Subscribed 23.25 times.
- Qualified Institutional Buyers (QIB): Subscribed 80.64 times.
The IPO was an offer for sale (OFS) of 1.88 crore shares, with no fresh issue component. Post-IPO, promoter shareholding reduced from 69.73% to 60.61%.
Anchor Investor Participation
On December 11, 2024, the company raised ₹1,120.18 crores from anchor investors, further boosting market anticipation for the IPO.
IPO Pricing and Lot Size
- Price Band: ₹1,265–₹1,329 per share.
- Lot Size: 11 shares, requiring a minimum investment of ₹14,619 for retail investors.
The issue reserved:
- 30% for QIBs,
- 15% for NIIs, and
- 10% for retail investors.
Company Overview
Founded in 2006, Inventurus Knowledge Solutions (IKS Health) provides administrative and technological support services to the healthcare industry. Its offerings include:
- Medical documentation management.
- Virtual medical scribing.
- Clinical support and process streamlining for outpatient and inpatient care.
By automating and simplifying administrative tasks, IKS Health helps healthcare providers focus on patient care while improving operational efficiency.
Financial Performance
Inventurus Knowledge Solutions has shown impressive growth in recent years:
- Revenue Growth: 75.25% YoY between FY23 and FY24.
- Profit After Tax (PAT): Increased by 21.38% during the same period.
This strong financial performance, coupled with its niche in the healthcare IT sector, makes Inventurus Knowledge Solutions a compelling investment case.
Post-IPO Valuation
At the upper price band of ₹1,329 per share, the IPO valued Inventurus Knowledge Solutions at a market capitalization of ₹22,802.07 crores.
Lead Managers and Registrar
- Book-Running Lead Managers: ICICI Securities, Jefferies India, JM Financial, J.P. Morgan India, Nomura Financial Advisory.
- Registrar: Link Intime India Private Ltd.
Investor Sentiment
The strong listing and overwhelming subscription numbers underscore the growing demand for healthcare IT solutions in India and globally. Inventurus Knowledge Solutions has positioned itself as a leader in this space, addressing the critical needs of healthcare providers.
Conclusion
The debut of Inventurus Knowledge Solutions shares at a premium of 43% on NSE and 39.65% on BSE reflects the positive market sentiment surrounding the company. With robust financial growth and a unique value proposition in the healthcare IT space, the stock is poised for further growth.
Investors are optimistic about its potential to sustain growth, driven by its innovative solutions and expanding market opportunities in the healthcare sector. Inventurus Knowledge Solutions' strong debut is a testament to the increasing importance of technology-driven healthcare services.